{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:11:53Z","timestamp":1767917513383,"version":"3.49.0"},"reference-count":78,"publisher":"Elsevier","isbn-type":[{"value":"9780443186691","type":"print"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["EMR\/2016\/007034"],"award-info":[{"award-number":["EMR\/2016\/007034"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/bs.pmbts.2023.01.010","type":"book-chapter","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T08:13:27Z","timestamp":1677744807000},"page":"241-260","source":"Crossref","is-referenced-by-count":14,"title":["Epigenetic regulation of pluripotency inducer genes NANOG and SOX2 in human prostate cancer"],"prefix":"10.1016","member":"78","reference":[{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.010_bb0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrg1748","article-title":"The epigenetic progenitor origin of human cancer","volume":"7","author":"Feinberg","year":"2006","journal-title":"Nat Rev Genet"},{"key":"10.1016\/bs.pmbts.2023.01.010_bb0015","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev.pathol.3.121806.151442","article-title":"Epigenetic changes in cancer","volume":"4","author":"Iacobuzio-Donahue","year":"2009","journal-title":"Annu Rev Pathol: Mech Dis"},{"issue":"9","key":"10.1016\/bs.pmbts.2023.01.010_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a019505","article-title":"Epigenetic determinants of cancer","volume":"8","author":"Baylin","year":"2016","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.010_bb0025","article-title":"Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials","volume":"4","author":"Cheng","year":"2019","journal-title":"Signal Transduct Target Ther"},{"issue":"5618","key":"10.1016\/bs.pmbts.2023.01.010_bb0030","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1126\/science.1083557","article-title":"Chromosomal instability and tumors promoted by DNA hypomethylation","volume":"300","author":"Eden","year":"2003","journal-title":"Science"},{"issue":"10","key":"10.1016\/bs.pmbts.2023.01.010_bb0035","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/nrd2137","article-title":"Tumour-initiating cells: challenges and opportunities for anticancer drug discovery","volume":"8","author":"Zhou","year":"2009","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"10.1016\/bs.pmbts.2023.01.010_bb0040","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrc2499","article-title":"Cancer stem cells in solid tumours: accumulating evidence and unresolved questions","volume":"8","author":"Visvader","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/bs.pmbts.2023.01.010_bb0045","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"issue":"November","key":"10.1016\/bs.pmbts.2023.01.010_bb0050","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1164270","article-title":"Generation of mouse induced pluripotent cells without viral vecotrs","volume":"322","author":"Okita","year":"2008","journal-title":"Science"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.010_bb0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.stem.2012.12.007","article-title":"The sox family of transcription factors: versatile regulators of stem and progenitor cell fate","volume":"12","author":"Sarkar","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.01.010_bb0060","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1534-5807(02)00223-X","article-title":"Twenty pairs of Sox: extent, homology, and nomenclature of the mouse and human Sox transcription factor gene families","volume":"3","author":"Schepers","year":"2002","journal-title":"Dev Cell"},{"issue":"March","key":"10.1016\/bs.pmbts.2023.01.010_bb0065","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.semcancer.2019.03.004","article-title":"The role of SOX family members in solid tumours and metastasis","volume":"67","author":"Grimm","year":"2020","journal-title":"Semin Cancer Biol"},{"issue":"December 2018","key":"10.1016\/bs.pmbts.2023.01.010_bb0070","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.semcancer.2019.08.007","article-title":"SOX2 in development and cancer biology","volume":"67","author":"Novak","year":"2020","journal-title":"Semin Cancer Biol"},{"issue":"11","key":"10.1016\/bs.pmbts.2023.01.010_bb0075","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/bjc.2011.159","article-title":"An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer","volume":"104","author":"Lee","year":"2011","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.010_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-23630-x","article-title":"High throughput screening identifies SOX2 as a super pioneer factor that inhibits DNA methylation maintenance at its binding sites","volume":"12","author":"Vanzan","year":"2021","journal-title":"Nat Commun"},{"issue":"OCT","key":"10.1016\/bs.pmbts.2023.01.010_bb0085","first-page":"1","article-title":"Targeting SOX2 as a therapeutic strategy in glioblastoma","volume":"6","author":"Garros-Regulez","year":"2016","journal-title":"Front Oncology"},{"issue":"31","key":"10.1016\/bs.pmbts.2023.01.010_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciadv.abn3986","article-title":"A SOX2-engineered epigenetic silencer factor represses the glioblastoma genetic program and restrains tumor development","volume":"8","author":"Benedetti","year":"2022","journal-title":"Sci Adv"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.01.010_bb0095","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/emm.2005.33","article-title":"Identification of a putative transactivation domain in human Nanog","volume":"37","author":"Oh","year":"2005","journal-title":"Exp Mol Med"},{"issue":"6","key":"10.1016\/bs.pmbts.2023.01.010_bb0100","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/sj.cr.7290193","article-title":"Identification of two distinct transactivation domains in the pluripotency sustaining factor nanog","volume":"13","author":"Pan","year":"2003","journal-title":"Cell Res"},{"issue":"14","key":"10.1016\/bs.pmbts.2023.01.010_bb0105","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1101\/gad.9.14.1679","article-title":"The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain","volume":"9","author":"Herr","year":"1995","journal-title":"Genes Dev"},{"issue":"5","key":"10.1016\/bs.pmbts.2023.01.010_bb0110","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ng.127","article-title":"An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors","volume":"40","author":"Ben-Porath","year":"2008","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.010_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-017-0596-9","article-title":"Epigenetics in cancer stem cells","volume":"16","author":"Toh","year":"2017","journal-title":"Mol Cancer"},{"issue":"11","key":"10.1016\/bs.pmbts.2023.01.010_bb0120","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrg.2017.57","article-title":"The interplay of epigenetic marks during stem cell differentiation and development","volume":"18","author":"Atlasi","year":"2017","journal-title":"Nat Rev Genet"},{"issue":"9","key":"10.1016\/bs.pmbts.2023.01.010_bb0125","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nrg887","article-title":"Chromatin modification and epigenetic reprogramming in mammalian development","volume":"3","author":"Li","year":"2002","journal-title":"Nat Rev Genet"},{"issue":"9","key":"10.1016\/bs.pmbts.2023.01.010_bb0130","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1046\/j.1365-2443.2002.00574.x","article-title":"Epigenetic marks by DNA methylation specific to stem, germ and somatic cells in mice","volume":"7","author":"Shiota","year":"2002","journal-title":"Genes Cells"},{"issue":"5","key":"10.1016\/bs.pmbts.2023.01.010_bb0135","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0092-8674(00)81532-9","article-title":"Methylation-induced repression-belts, braces, and chromatin","volume":"99","author":"Bird","year":"1999","journal-title":"Cell"},{"issue":"6","key":"10.1016\/bs.pmbts.2023.01.010_bb0140","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nrg1349","article-title":"Epigenomics: beyond CpG islands","volume":"5","author":"Fazzari","year":"2004","journal-title":"Nat Rev Genet"},{"issue":"10","key":"10.1016\/bs.pmbts.2023.01.010_bb0145","doi-asserted-by":"crossref","first-page":"9627","DOI":"10.1074\/jbc.M413822200","article-title":"Stage-by-stage change in DNA methylation status of Dnmt1 locus during mouse early development","volume":"280","author":"Ko","year":"2005","journal-title":"J Biol Chem"},{"issue":"17","key":"10.1016\/bs.pmbts.2023.01.010_bb0150","doi-asserted-by":"crossref","first-page":"12163","DOI":"10.1074\/jbc.M513782200","article-title":"DNA methylation-dependent epigenetic regulation of dimethylarginine dimethylaminohydrolase 2 gene in trophoblast cell lineage","volume":"281","author":"Tomikawa","year":"2006","journal-title":"J Biol Chem"},{"issue":"August","key":"10.1016\/bs.pmbts.2023.01.010_bb0155","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.1063127","article-title":"Translating the histone code","volume":"293","author":"Jenuwein","year":"2001","journal-title":"Science (New York, NY)"},{"issue":"17","key":"10.1016\/bs.pmbts.2023.01.010_bb0160","doi-asserted-by":"crossref","first-page":"17063","DOI":"10.1074\/jbc.M309002200","article-title":"Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells and trophoblast stem cells","volume":"279","author":"Hattori","year":"2004","journal-title":"J Biol Chem"},{"issue":"Suppl. 4","key":"10.1016\/bs.pmbts.2023.01.010_bb0165","doi-asserted-by":"crossref","first-page":"16485","DOI":"10.1073\/pnas.182427299","article-title":"Induction and maintenance of nonsymmetrical DNA methylation in Neurospora","volume":"99","author":"Selker","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.01.010_bb0170","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/embo-reports\/kvf053","article-title":"Histone acetylation: a switch between repressive and permissive chromatin. Second in review on chromatin dynamics","volume":"3","author":"Eberharter","year":"2002","journal-title":"EMBO Rep"},{"issue":"7066","key":"10.1016\/bs.pmbts.2023.01.010_bb0175","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/nature04112","article-title":"A histone H3 methyltransferase controls epigenetic events required for meiotic prophase","volume":"438","author":"Hayashi","year":"2005","journal-title":"Nature"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.01.010_bb0180","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0955-0674(02)00335-6","article-title":"The many faces of histone lysine methylation","volume":"14","author":"Lachner","year":"2002","journal-title":"Curr Opin Cell Biol"},{"issue":"14","key":"10.1016\/bs.pmbts.2023.01.010_bb0185","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1101\/gad.989402","article-title":"G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis","volume":"16","author":"Tachibana","year":"2002","journal-title":"Genes Dev"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.010_bb0190","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/npp.2012.112","article-title":"DNA methylation and its basic function","volume":"38","author":"Moore","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.01.010_bb0195","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res"},{"issue":"8","key":"10.1016\/bs.pmbts.2023.01.010_bb0200","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.bbagrm.2014.02.013","article-title":"Chromatin dynamics: interplay between remodeling enzymes and histone modifications","volume":"1839","author":"Swygert","year":"2014","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.010_bb396","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ng1143","article-title":"Trimethylated lysine 9 of histone H3 is a mark for DNA methylation in Neurospora crassa","volume":"34","author":"Tamaru","year":"2003","journal-title":"Nat Genet"},{"issue":"JAN","key":"10.1016\/bs.pmbts.2023.01.010_bb0205","first-page":"1","article-title":"Non-coding RNA: what is functional and what is junk?","volume":"5","author":"Palazzo","year":"2015","journal-title":"Front Genet"},{"issue":"SEP","key":"10.1016\/bs.pmbts.2023.01.010_bb0210","first-page":"1","article-title":"The non-coding oncogene: a case of missing DNA evidence?","volume":"3","author":"Shahrouki","year":"2012","journal-title":"Front Genet"},{"issue":"4","key":"10.1016\/bs.pmbts.2023.01.010_bb0215","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.juro.2014.04.013","article-title":"Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies","volume":"192","author":"Partin","year":"2014","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/bs.pmbts.2023.01.010_bb0220","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.juro.2011.06.052","article-title":"Predicting prostate biopsy result in men with prostate specific antigen 2.0 to 10.0 ng\/ml using an investigational prostate cancer methylation assay","volume":"186","author":"Baden","year":"2011","journal-title":"J Urol"},{"issue":"12","key":"10.1016\/bs.pmbts.2023.01.010_bb0225","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/pros.23385","article-title":"Epigenetic risk score improves prostate cancer risk assessment","volume":"77","author":"Van Neste","year":"2017","journal-title":"Prostate"},{"issue":"6","key":"10.1016\/bs.pmbts.2023.01.010_bb0230","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1074\/jbc.R800063200","article-title":"Regulation of pluripotency and reprogramming by transcription factors","volume":"284","author":"Pei","year":"2009","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.010_bb0235","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bbadis.2016.11.001","article-title":"SOX2 function and hedgehog signaling pathway are co-conspirators in promoting androgen independent prostate cancer","volume":"1863","author":"Kar","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"7143","key":"10.1016\/bs.pmbts.2023.01.010_bb0240","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nature05918","article-title":"Stability and flexibility of epigenetic gene regulation in mammalian development","volume":"447","author":"Reik","year":"2007","journal-title":"Nature"},{"issue":"4","key":"10.1016\/bs.pmbts.2023.01.010_bb0245","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006098","article-title":"Signal transduction in cancer","volume":"5","author":"Sever","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"10.1016\/bs.pmbts.2023.01.010_bb0250","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/jmcb\/mjr002","article-title":"SOX2 promotes tumorigenesis and increases the anti-apoptotic property of human prostate cancer cell","volume":"3","author":"Jia","year":"2011","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/bs.pmbts.2023.01.010_bb0255","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1101\/sqb.2010.75.007","article-title":"Cancer epigenetics: from disruption of differentiation programs to the emergence of cancer stem cells","volume":"75","author":"Scaffidi","year":"2010","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"4","key":"10.1016\/bs.pmbts.2023.01.010_bb0260","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.ejca.2012.09.023","article-title":"Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells","volume":"49","author":"Le Magnen","year":"2013","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/bs.pmbts.2023.01.010_bb0265","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.juro.2009.12.092","article-title":"Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells","volume":"183","author":"Bae","year":"2010","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.010_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053701","article-title":"Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer","volume":"8","author":"Kregel","year":"2013","journal-title":"PLoS One"},{"issue":"52","key":"10.1016\/bs.pmbts.2023.01.010_bb0275","doi-asserted-by":"crossref","first-page":"21276","DOI":"10.1073\/pnas.1117029108","article-title":"Molecular classification of prostate cancer using curated expression signatures","volume":"108","author":"Markert","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.01.010_bb0280","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1513\/pats.201201-001MS","article-title":"The cancer epigenome: its origins, contributions to tumorigenesis, and translational implications","volume":"9","author":"Baylin","year":"2012","journal-title":"Proc Am Thorac Soc"},{"issue":"6320","key":"10.1016\/bs.pmbts.2023.01.010_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/science.aah4307","article-title":"SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer","volume":"355","author":"Mu","year":"2017","journal-title":"Science"},{"issue":"8","key":"10.1016\/bs.pmbts.2023.01.010_bb0290","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/s41388-021-02157-x","article-title":"SOX2 mediates metabolic reprogramming of prostate cancer cells","volume":"41","author":"de Wet","year":"2022","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.010_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-018-0426-4","article-title":"Cancer stem cells as key drivers of tumour progression","volume":"25","author":"Ayob","year":"2018","journal-title":"J Biomed Sci"},{"issue":"11","key":"10.1016\/bs.pmbts.2023.01.010_bb0300","doi-asserted-by":"crossref","first-page":"12372","DOI":"10.18632\/oncotarget.6029","article-title":"SOX2 boosts major tumor progression genes in prostate cancer and is a functional biomarker of lymph node metastasis","volume":"7","author":"Russo","year":"2016","journal-title":"Oncotarget"},{"issue":"36","key":"10.1016\/bs.pmbts.2023.01.010_bb0305","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1038\/onc.2011.114","article-title":"NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation","volume":"30","author":"Nishino Jeter","year":"2011","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/bs.pmbts.2023.01.010_bb0310","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/ncb2308","article-title":"In vitro generation of human cells with cancer stem cell properties","volume":"13","author":"Scaffidi","year":"2011","journal-title":"Nat Cell Biol"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.01.010_bb0315","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1101\/gr.147942.112","article-title":"Dynamic DNA methylation across diverse human cell lines and tissues","volume":"23","author":"Varley","year":"2013","journal-title":"Genome Res"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.01.010_bb0320","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3892\/ol.2014.2274","article-title":"Immunohistochemical expression of four different stem cell markers in prostate cancer: high expression of NANOG in conjunction with hypoxia-inducible factor-1\u03b1 expression is involved in prostate epithelial malignancy","volume":"8","author":"Miyazawa","year":"2014","journal-title":"Oncol Lett"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.01.010_bb0325","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.devcel.2018.11.035","article-title":"SPOP promotes nanog destruction to suppress stem cell traits and prostate cancer progression","volume":"48","author":"Zhang","year":"2019","journal-title":"Dev Cell"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.01.010_bb0330","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.devcel.2018.11.033","article-title":"AMPK promotes SPOP-mediated NANOG degradation to regulate prostate cancer cell stemness","volume":"48","author":"Wang","year":"2019","journal-title":"Dev Cell"},{"issue":"6","key":"10.1016\/bs.pmbts.2023.01.010_bb0335","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000320866","article-title":"Nanog is highly expressed in ovarian serous cystadenocarcinoma and correlated with clinical stage and pathological grade","volume":"77","author":"Pan","year":"2011","journal-title":"Pathobiology"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.010_bb0340","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/aps.2014.18","article-title":"Androgen receptor: structure, role in prostate cancer and drug discovery","volume":"36","author":"Tan","year":"2015","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.010_bb397","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-015-0864-1","article-title":"Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients","volume":"17","author":"Lallous","year":"2016","journal-title":"Genome Biol"},{"issue":"39","key":"10.1016\/bs.pmbts.2023.01.010_bb0345","doi-asserted-by":"crossref","first-page":"64447","DOI":"10.18632\/oncotarget.10901","article-title":"Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer","volume":"7","author":"Wadosky","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.010_bb0350","first-page":"2","article-title":"Wnt\/\u03b2-catenin signal transduction pathway in prostate cancer and associated drug resistance","volume":"12","author":"Wang","year":"2021","journal-title":"Discov Oncol"},{"issue":"823","key":"10.1016\/bs.pmbts.2023.01.010_bb0355","first-page":"823","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Church","year":"2013","journal-title":"Science"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.010_bb0360","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nprot.2011.431","article-title":"A transcription activator-like effector toolbox for genome engineering","volume":"7","author":"Sanjana","year":"2012","journal-title":"Nat Protoc"},{"issue":"11","key":"10.1016\/bs.pmbts.2023.01.010_bb0365","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1073\/pnas.94.11.5525","article-title":"Design of polydactyl zinc-finger proteins for unique addressing within complex genomes","volume":"94","author":"Liu","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/bs.pmbts.2023.01.010_bb0370","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.tibtech.2013.04.004","article-title":"ZFN, TALEN, and CRISPR\/Cas-based methods for genome engineering","volume":"31","author":"Gaj","year":"2013","journal-title":"Trends Biotechnol"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.010_bb0375","article-title":"May I cut in? Gene editing approaches in human induced pluripotent stem cells","volume":"6","author":"Brookhouser","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.010_bb0380","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nprot.2016.152","article-title":"Efficient, footprint-free human iPSC genome editing by consolidation of Cas9\/CRISPR and piggyBac technologies","volume":"12","author":"Wang","year":"2017","journal-title":"Nat Protoc"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.01.010_bb0385","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.stem.2017.12.001","article-title":"CRISPR-based chromatin remodeling of the endogenous Oct4 or Sox2 locus enables reprogramming to pluripotency","volume":"22","author":"Liu","year":"2018","journal-title":"Cell Stem Cell"}],"container-title":["Progress in Molecular Biology and Translational Science","Epigenetics in Health and Disease - Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117323000212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117323000212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:04:42Z","timestamp":1762560282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117323000212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9780443186691"],"references-count":78,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2023.01.010","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}